Vaxxinity Inc (VAXX)
0.05
-0.04
(-44.44%)
USD |
OTCM |
Sep 18, 15:14
Vaxxinity Shareholders Equity (Quarterly): 13.41M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 13.41M |
September 30, 2023 | 23.70M |
June 30, 2023 | 35.01M |
March 31, 2023 | 46.13M |
December 31, 2022 | 62.18M |
September 30, 2022 | 80.26M |
Date | Value |
---|---|
June 30, 2022 | 97.34M |
March 31, 2022 | 112.66M |
December 31, 2021 | 128.62M |
September 30, 2021 | -157.37M |
June 30, 2021 | -141.82M |
December 31, 2020 | -87.38M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-157.37M
Minimum
Sep 2021
128.62M
Maximum
Dec 2021
17.73M
Average
40.57M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 6.102M |
IGC Pharma Inc | 7.88M |
NovaBay Pharmaceuticals Inc | -0.617M |
Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 44.31M |
Total Liabilities (Quarterly) | 30.90M |